Abstract
Today, about half of all the prescriptions are filled with a generic equivalent of a brand-name drug. Because of the decrease in price, we are now switching from branded drugs to generic drugs and there is a steep inclination towards generic drugs by both patients and health care professionals without compromising the efficacy and safety of the drug. Any drug identified as a generic drug is the bioequivalent of the brandname drug and is typically sold at substantially low cost from the branded one, hence, easily affordable by common man. The present review encompasses the comprehensive portfolio of generic drugs comprising description, evolvement, approval, pharmaco-economics, demand, current scenario and future perspective of the generic drugs. It also throws some light on the position of Indian pharma sector in generics market.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
